Bilosomes: Next-Generation Nanocarriers Advancing Cancer Drug Delivery
International Journal of Drug Delivery Technology · 08.06.2026 · 16 (47s)
DOI: 10.25258/ijddt.16.47s.80 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 08.06.2026. Verfasst von Harshada Shiware und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Bilosomes are bile salt-integrated nanovesicles that offer increased stability, flexibility and drug-protective properties compared with standard lipid carriers. Their composition-Phospholipids, cholesterol, non-ionic surfactants and bile saltsenables efficient loading of both hydrophilic and lipophilic drugs while enhancing permeability and resistance to gastrointestinal degradation. This review compiles the structural features and preparation methods of bilosomes and includes a comparative discussion with other vesicular systems. Particular emphasis is placed on the application of bilosomes in cancer therapy. Bilosomal formulations have demonstrated greater solubility, increased cellular absorption, deeper tumor penetration, higher cytotoxic and pro-apoptotic effects and less systemic toxicity in malignancies of the breast, lung, liver, colon and skin. Surface-engineered bilosomes, including PEGylated and ligand-modified systems, significantly boost targeting efficiency and therapeutic effects. Beyond oncology, bilosomes show potential in antiviral, dermatologic, ophthalmic and brain-targeted drug delivery. Overall, bilosomes represent a promising next-generation nanocarrier capable of overcoming key delivery obstacles. However, further in-vivo and clinical research is needed to support its translation into clinical application.
Zitieren
APA
Shiware, H., Mane, M., Deshmukh, A., Bhadalekar, M., Koli, S., Khamkar, T., & Mendigeri, A. (2026). Bilosomes: Next-Generation Nanocarriers Advancing Cancer Drug Delivery. International Journal of Drug Delivery Technology, 16(47s). https://doi.org/10.25258/ijddt.16.47s.80
Vancouver
Shiware H, Mane M, Deshmukh A, Bhadalekar M, Koli S, Khamkar T, et al. Bilosomes: Next-Generation Nanocarriers Advancing Cancer Drug Delivery. International Journal of Drug Delivery Technology. 2026;16(47s). doi:10.25258/ijddt.16.47s.80
BibTeX
@article{Shiware2026,
author = {Shiware, Harshada and Mane, Manisha and Deshmukh, Akshada and Bhadalekar, Mayuri and Koli, Snehal and Khamkar, Tejashree and Mendigeri, Akshata},
title = {Bilosomes: Next-Generation Nanocarriers Advancing Cancer Drug Delivery},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {47s},
doi = {10.25258/ijddt.16.47s.80}
}
EUVIMED